Cargando…

Clinical Associations of Human T-Lymphotropic Virus Type 1 Infection in an Indigenous Australian Population

INTRODUCTION: In resource-poor areas, infectious diseases may be important causes of morbidity among individuals infected with the Human T-Lymphotropic Virus type 1 (HTLV-1). We report the clinical associations of HTLV-1 infection among socially disadvantaged Indigenous adults in central Australia....

Descripción completa

Detalles Bibliográficos
Autores principales: Einsiedel, Lloyd, Spelman, Tim, Goeman, Emma, Cassar, Olivier, Arundell, Mick, Gessain, Antoine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894183/
https://www.ncbi.nlm.nih.gov/pubmed/24454973
http://dx.doi.org/10.1371/journal.pntd.0002643
_version_ 1782299813031706624
author Einsiedel, Lloyd
Spelman, Tim
Goeman, Emma
Cassar, Olivier
Arundell, Mick
Gessain, Antoine
author_facet Einsiedel, Lloyd
Spelman, Tim
Goeman, Emma
Cassar, Olivier
Arundell, Mick
Gessain, Antoine
author_sort Einsiedel, Lloyd
collection PubMed
description INTRODUCTION: In resource-poor areas, infectious diseases may be important causes of morbidity among individuals infected with the Human T-Lymphotropic Virus type 1 (HTLV-1). We report the clinical associations of HTLV-1 infection among socially disadvantaged Indigenous adults in central Australia. METHODOLOGY AND PRINCIPAL FINDINGS: HTLV-1 serological results for Indigenous adults admitted 1(st) January 2000 to 31(st) December 2010 were obtained from the Alice Springs Hospital pathology database. Infections, comorbid conditions and HTLV-1 related diseases were identified using ICD-10 AM discharge morbidity codes. Relevant pathology and imaging results were reviewed. Disease associations, admission rates and risk factors for death were compared according to HTLV-1 serostatus. HTLV-1 western blots were positive for 531 (33.3%) of 1595 Indigenous adults tested. Clinical associations of HTLV-1 infection included bronchiectasis (adjusted Risk Ratio, 1.35; 95% CI, 1.14–1.60), blood stream infections (BSI) with enteric organisms (aRR, 1.36; 95% CI, 1.05–1.77) and admission with strongyloidiasis (aRR 1.38; 95% CI, 1.16–1.64). After adjusting for covariates, HTLV-1 infection remained associated with increased numbers of BSI episodes (adjusted negative binomial regression, coefficient, 0.21; 95% CI, 0.02–0.41) and increased admission numbers with strongyloidiasis (coefficient, 0.563; 95% CI, 0.17–0.95) and respiratory conditions including asthma (coefficient, 0.99; 95% CI, 0.27–1.7), lower respiratory tract infections (coefficient, 0.19; 95% CI, 0.04–0.34) and bronchiectasis (coefficient, 0.60; 95% CI, 0.02–1.18). Two patients were admitted with adult T-cell Leukemia/Lymphoma, four with probable HTLV-1 associated myelopathy and another with infective dermatitis. Independent predictors of mortality included BSI with enteric organisms (aRR 1.78; 95% CI, 1.15–2.74) and bronchiectasis (aRR 2.07; 95% CI, 1.45–2.98). CONCLUSION: HTLV-1 infection contributes to morbidity among socially disadvantaged Indigenous adults in central Australia. This is largely due to an increased risk of other infections and respiratory disease. The spectrum of HTLV-1 related diseases may vary according to the social circumstances of the affected population.
format Online
Article
Text
id pubmed-3894183
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38941832014-01-21 Clinical Associations of Human T-Lymphotropic Virus Type 1 Infection in an Indigenous Australian Population Einsiedel, Lloyd Spelman, Tim Goeman, Emma Cassar, Olivier Arundell, Mick Gessain, Antoine PLoS Negl Trop Dis Research Article INTRODUCTION: In resource-poor areas, infectious diseases may be important causes of morbidity among individuals infected with the Human T-Lymphotropic Virus type 1 (HTLV-1). We report the clinical associations of HTLV-1 infection among socially disadvantaged Indigenous adults in central Australia. METHODOLOGY AND PRINCIPAL FINDINGS: HTLV-1 serological results for Indigenous adults admitted 1(st) January 2000 to 31(st) December 2010 were obtained from the Alice Springs Hospital pathology database. Infections, comorbid conditions and HTLV-1 related diseases were identified using ICD-10 AM discharge morbidity codes. Relevant pathology and imaging results were reviewed. Disease associations, admission rates and risk factors for death were compared according to HTLV-1 serostatus. HTLV-1 western blots were positive for 531 (33.3%) of 1595 Indigenous adults tested. Clinical associations of HTLV-1 infection included bronchiectasis (adjusted Risk Ratio, 1.35; 95% CI, 1.14–1.60), blood stream infections (BSI) with enteric organisms (aRR, 1.36; 95% CI, 1.05–1.77) and admission with strongyloidiasis (aRR 1.38; 95% CI, 1.16–1.64). After adjusting for covariates, HTLV-1 infection remained associated with increased numbers of BSI episodes (adjusted negative binomial regression, coefficient, 0.21; 95% CI, 0.02–0.41) and increased admission numbers with strongyloidiasis (coefficient, 0.563; 95% CI, 0.17–0.95) and respiratory conditions including asthma (coefficient, 0.99; 95% CI, 0.27–1.7), lower respiratory tract infections (coefficient, 0.19; 95% CI, 0.04–0.34) and bronchiectasis (coefficient, 0.60; 95% CI, 0.02–1.18). Two patients were admitted with adult T-cell Leukemia/Lymphoma, four with probable HTLV-1 associated myelopathy and another with infective dermatitis. Independent predictors of mortality included BSI with enteric organisms (aRR 1.78; 95% CI, 1.15–2.74) and bronchiectasis (aRR 2.07; 95% CI, 1.45–2.98). CONCLUSION: HTLV-1 infection contributes to morbidity among socially disadvantaged Indigenous adults in central Australia. This is largely due to an increased risk of other infections and respiratory disease. The spectrum of HTLV-1 related diseases may vary according to the social circumstances of the affected population. Public Library of Science 2014-01-16 /pmc/articles/PMC3894183/ /pubmed/24454973 http://dx.doi.org/10.1371/journal.pntd.0002643 Text en © 2014 Einsiedel et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Einsiedel, Lloyd
Spelman, Tim
Goeman, Emma
Cassar, Olivier
Arundell, Mick
Gessain, Antoine
Clinical Associations of Human T-Lymphotropic Virus Type 1 Infection in an Indigenous Australian Population
title Clinical Associations of Human T-Lymphotropic Virus Type 1 Infection in an Indigenous Australian Population
title_full Clinical Associations of Human T-Lymphotropic Virus Type 1 Infection in an Indigenous Australian Population
title_fullStr Clinical Associations of Human T-Lymphotropic Virus Type 1 Infection in an Indigenous Australian Population
title_full_unstemmed Clinical Associations of Human T-Lymphotropic Virus Type 1 Infection in an Indigenous Australian Population
title_short Clinical Associations of Human T-Lymphotropic Virus Type 1 Infection in an Indigenous Australian Population
title_sort clinical associations of human t-lymphotropic virus type 1 infection in an indigenous australian population
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894183/
https://www.ncbi.nlm.nih.gov/pubmed/24454973
http://dx.doi.org/10.1371/journal.pntd.0002643
work_keys_str_mv AT einsiedellloyd clinicalassociationsofhumantlymphotropicvirustype1infectioninanindigenousaustralianpopulation
AT spelmantim clinicalassociationsofhumantlymphotropicvirustype1infectioninanindigenousaustralianpopulation
AT goemanemma clinicalassociationsofhumantlymphotropicvirustype1infectioninanindigenousaustralianpopulation
AT cassarolivier clinicalassociationsofhumantlymphotropicvirustype1infectioninanindigenousaustralianpopulation
AT arundellmick clinicalassociationsofhumantlymphotropicvirustype1infectioninanindigenousaustralianpopulation
AT gessainantoine clinicalassociationsofhumantlymphotropicvirustype1infectioninanindigenousaustralianpopulation